Schuyler Kevin has filed 9 insider transactions across 2 companies since May 2023.
Most recent transaction: a purchase of 25000 shares of Twin Vee PowerCats, Co. ($VEEE) on March 19, 2026.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 19, 2026 | Twin Vee PowerCats, Co. | $VEEE | Schuyler Kevin | Director | P | Common stock | 25000 | $0.41 | 31,252.0000 | 2,237,299 | 399.87% | 1.12% |
| May 29, 2025 | ADIAL PHARMACEUTICALS, INC. | $ADIL | Schuyler Kevin | Director | A | Stock Option (Right to Buy) | 28000 | $0.00 | 28,000.0000 | 6,539,760 | 9999.99% | 0.43% |
| May 19, 2025 | Twin Vee PowerCats, Co. | $VEEE | Schuyler Kevin | Director | A | Stock Option (Right to Buy) | 3000 | $0.00 | 3,000.0000 | 14,874,480 | 9999.99% | 0.02% |
| Nov. 26, 2024 | Twin Vee PowerCats, Co. | $VEEE | Schuyler Kevin | Director | A | Stock Option (Right to Buy) | 3364 | $0.00 | 3,364.0000 | 9,520,000 | 9999.99% | 0.04% |
| Nov. 26, 2024 | Twin Vee PowerCats, Co. | $VEEE | Schuyler Kevin | Director | A | Common Stock | 61166 | $0.00 | 73,530.0000 | 9,520,000 | 494.71% | 0.64% |
| Aug. 16, 2024 | Twin Vee PowerCats, Co. | $VEEE | Schuyler Kevin | Director | A | Stock Options (Right to Buy) | 5500 | $0.00 | 5,500.0000 | 9,520,000 | 9999.99% | 0.06% |
| March 25, 2024 | ADIAL PHARMACEUTICALS, INC. | $ADIL | Schuyler Kevin | Director | A | Stock Option (Right to Buy) | 12000 | $0.00 | 12,000.0000 | 1,424,661 | 9999.99% | 0.84% |
| Sept. 29, 2023 | ADIAL PHARMACEUTICALS, INC. | $ADIL | Schuyler Kevin | Director | P | Common Stock | 700 | $2.74 | 6,589.0000 | 1,131,436 | 11.89% | 0.06% |
| May 23, 2023 | ADIAL PHARMACEUTICALS, INC. | $ADIL | Schuyler Kevin | Director | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 26,463,559 | 9999.99% | 0.19% |